Both loss of E-Cadherin expression in cancers derived from E-Cadherin positive normal cells and upregulation in malignancies derived from E-cadherin negative normal tend to be linked to unfavorable tumor phenotype and disease outcome. Here, CDH1 is linked to cancer.